Xerostomia (Dry Mouth) Therapeutics Market Report Forecasts Impressive Growth by 2022 - Scalar Market Research

Xerostomia is a medical condition of dry mouth resulting from reduced or absent saliva flow. It is not a disease; however, it might be a symptom of a medical condition or sometimes even a side effect of some kind of medication. It is more common in old aged people and in people who tend to breathe through their mouth. Any reason which can lead to hypo-functioning of the salivary glands can give rise to this problem. Procedures like chemotherapy and radiotherapy can also affect the salivary glands and condition of dry mouth. This report studies the current and future aspects of the Xerostomia Therapeutics market.

Download Free Sample: https://www.scalarmarketresearch.com/request-sample.php?id=1364

The report on the global xerostomia (dry mouth) therapeutics market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.

Enquiry Before Buying: https://www.scalarmarketresearch.com/enquire-before-buy.php?id=1364

KEY PREMIUM INDUSTRY INSIGHTS

1. The xerostomia therapeutics market is growing at a rapid pace during the forecasted period mainly because of increasing usage of medication and adoption of treatment procedures like chemotherapy and radiotherapy. The rise in geriatric population is also promoting the market growth.

2. Easy availability of cost-effective medications is one of the major market driving factors. Increasing incidences of diseases like cancer, hypertension, diabetes, or psychological disorders accounts for usage of prescribed medications which leads to dry mouth; this feature is contributing towards the growth of xerostomia therapeutics market.

The global xerostomia therapeutics market is divided into four major geographical segments which are North America, Europe, Asia-Pacific, and Rest of the World (RoW). The North America region holds the highest market share and contributes the highest revenue. The region continues to dominate the global IVF devices and consumables market during the forecasted period because of increasing incidences of diseases that lead to dry mouth, and rising usage of prescribed medications. Next in line is the Asia Pacific region which is witnessing a rapid market growth due to rise in geriatric population and increase in usage of prescribed medication. In addition, there is rise in awareness regarding the health issues and medicine side effects which is also boosting the market growth further.

MARKET SEGMENTATION

This report analyzes the xerostomia (dry mouth) therapeutics market by the following segments:

Xerostomia (Dry Mouth) Therapeutics Market, by Type

1. OTC
2. Prescription

Xerostomia (Dry Mouth) Therapeutics Market, by Product

1. Salivary Stimulants
2. Salivary Substitutes
3. Dentifrices

KEY MARKET PLAYERS

Key players in the xerostomia (dry mouth) therapeutics market include:

1. Acacia Pharma
2. Parnell Pharmaceuticals, Inc.
3. Pfizer, Inc.
4. GlaxoSmithKline plc
5. Church & Dwight Co., Inc.
6. Lupin
7. Sun Pharmaceutical Industries, Ltd.
8. Hikma Pharmaceuticals PLC
9. Pendopharm
10. OraCoat

Browse Report: https://www.scalarmarketresearch.com/market-reports/xerostomia-dry-mouth-therapeutics-market

About Scalar Market Research

Scalar Market Research Inc. aspires to assist organizations from around the world to achieve their business goal with premium market research reports and consulting services. Our real-time industry tracking with the help of advanced analytics offers a crystal clear view of all the activities in niche markets. Our team, with thorough global understanding, works relentlessly to gather the necessary market insights, including customer analysis, competitions and global forecast.

Find out more about our services at: www.scalarmarketresearch.com

Contact:
8770 W Bryn Mawr Ave.,
Suite 1300
Chicago, IL 60631
Tel.: +1-800-213-5170 (U.S./Canada Toll-free)
Email: sales@scalarmarketresearch.com

This release was published on openPR.